Prostate News and Research

RSS

Double whammy of vitamin D and anti-inflammatory zaps prostate cancer cells

Scientists from Stanford University say they have discovered that vitamin D, known as the "sunshine vitamin,"can limit the growth of prostate cancer cells when combined with non-steroidal anti-inflammatory drugs.

6 Sep 2005

Prostate cancer manipulates an important group of signaling proteins called Wnts to establish itself in bone

Prostate cancer is a cruel disease. Left untreated, prostate cancer cells often metastasize, or spread, to bone where they form fracture-prone tumors that are extremely painful.

1 Sep 2005

Men with breast cancer gene at risk of pancreatic and prostate cancers

The very same genetic mutation which has been previously linked to the development of breast cancer in women may also be responsible for some cancers in men.

1 Sep 2005

Mutation in the BRAC2 breast cancer gene may also increase the risk of bone and throat cancers

A genetic mutation implicated in an increased risk of breast and ovarian cancers also significantly increases the risk of pancreatic and prostate cancers in men, finds research in the Journal of Medical Genetics.

1 Sep 2005

Compound called GRN163L blocks lung cancer

Researchers at UT Southwestern Medical Center have found a compound that shows promise as a way to block the spread, or metastasis, of lung cancer.

1 Sep 2005

Low doses of the active form of vitamin D and non-steroidal anti-inflammatory drugs form one-two punch against prostate cancer cells

Low doses of the active form of vitamin D and non-steroidal anti-inflammatory drugs, taken in combination, have been shown to act as a powerful one-two punch that knocks down the growth of prostate cancer cells.

1 Sep 2005

Another use for Botox - enlarged prostate

Botox, appears to alter specific cellular processes that contribute to prostate enlargement according to new study results presented by researchers from the University of Pittsburgh and Chang Gung Memorial Hospital in Taiwan at the International Continence Society annual meeting in Montreal.

31 Aug 2005

Minimally invasive prostate removal aided by a robot has possible benefits, high cost

Although minimally invasive prostate removal aided by a robot can lead to less blood loss, shorter hospital stays and fewer complications, there is no evidence that the procedure improves cure rates, according to a new technology assessment.

29 Aug 2005

First clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost

The phase I clinical study will enroll 20 patients with advanced solid cancers (including most common tumor types), and is the culmination of more than a decade of work by a team of researchers led by Professor Esther H. Chang, Ph.D. at the Lombardi Comprehensive Cancer Center.

25 Aug 2005

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

Lorus Therapeutics has announced the continued success in the development of its small molecule anticancer program with the selection of a sub-class of lead molecules from the Company's small molecule program.

24 Aug 2005

Non-invasive imaging may help predict type 1 diabetes and response to treatment in humans

A key obstacle to early detection of type 1 diabetes - as well as to rapid assessment of the effectiveness of therapeutic intervention - has been the lack of direct, non-invasive technologies to visualize inflammation in the pancreas, an early manifestation of disease.

22 Aug 2005

Analytical tool to help detect cancer

Scientists have long used ultra-fine glass tubes known as capillaries to analyze the chemical makeup of substances. Called capillary electrophoresis, or CE, the method applies high voltage to the capillaries, and by measuring the rate that the various materials move through the capillaries, researchers are able to identify individual compounds.

16 Aug 2005

Enzyme called matriptase, when left to its own devices, can cause cance

Scientists at the National Institute of Dental and Craniofacial Research (NIDCR) and colleagues report in animal studies that a single, scissor-like enzyme called matriptase, when left to its own devices, can cause cancer.

16 Aug 2005

New study shows testosterone treatment linked to prostate cancer

Researchers in the United States say that prostate cancer developed in 20 men within months to a few years after they began testosterone supplementation, to correct a deficiency of the hormone.

15 Aug 2005

Calcium fights prostate cancer

Calcium, more familiar in its role as one of the building blocks of the body, is being enlisted as a tool in the fight against prostate cancer.

15 Aug 2005

Activated Stat5 protein in prostate cancer can predict outcome, may help target treatment

Researchers from Lombardi Comprehensive Cancer Center at Georgetown University found that testing for an activated Stat5 protein in prostate tumor tissue effectively predicts which men have a form of prostate cancer that may become more aggressive and life threatening.

15 Aug 2005

Giving prostate cancer patients radiotherapy after surgery could help prevent the progression of their disease

When cancer is confined to the prostate, removal of the organ can successfully control the disease. However, for patients with cancer extending beyond the prostate the risk of recurrence after surgery can be 10–50%.

11 Aug 2005

Australian scientists rejuvenate the immune systems of mice and humans using a common hormone

The scientists, led by Associate Professor Richard Boyd and Dr Jayne Sutherland from the Monash Immunology and Stem Cell Laboratories, have revitalised the thymus which produces the T cells required to fight infection but which shuts down from early adulthood.

11 Aug 2005

Lifestyle changes may affect the progression of any type of cancer

Men with early stage prostate cancer who make intensive changes in diet and lifestyle may stop or perhaps even reverse the progression of their illness, according to a new study.

11 Aug 2005

FDA approval sought for Pfizer's new cancer drug

Drug company Pfizer has announced it has submitted a New Drug Application (NDA) for its cancer drug Sutent, to the U.S. Food and Drug Administration (FDA).

11 Aug 2005

Prostate News and Research

Double whammy of vitamin D and anti-inflammatory zaps prostate cancer cells

Prostate cancer manipulates an important group of signaling proteins called Wnts to establish itself in bone

Men with breast cancer gene at risk of pancreatic and prostate cancers

Mutation in the BRAC2 breast cancer gene may also increase the risk of bone and throat cancers

Compound called GRN163L blocks lung cancer

Low doses of the active form of vitamin D and non-steroidal anti-inflammatory drugs form one-two punch against prostate cancer cells

Another use for Botox - enlarged prostate

Minimally invasive prostate removal aided by a robot has possible benefits, high cost

First clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

Non-invasive imaging may help predict type 1 diabetes and response to treatment in humans

Analytical tool to help detect cancer

Enzyme called matriptase, when left to its own devices, can cause cance

New study shows testosterone treatment linked to prostate cancer

Calcium fights prostate cancer

Activated Stat5 protein in prostate cancer can predict outcome, may help target treatment

Giving prostate cancer patients radiotherapy after surgery could help prevent the progression of their disease

Australian scientists rejuvenate the immune systems of mice and humans using a common hormone

Lifestyle changes may affect the progression of any type of cancer

FDA approval sought for Pfizer's new cancer drug

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News